Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Applying to David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center · New York, New York
Answer a few short questions to share with the research team.